When someone is diagnosed with advanced lung cancer, one of the first questions that comes to mind is “Are there modern treatments that work better and cause fewer side effects?”
The good news is that today, medicine offers highly precise options known as targeted therapies. These treatments work differently from chemotherapy and have changed how doctors manage lung cancer treatment, especially when it has spread or cannot be removed surgically.
This blog explains how targeted therapies work, who can benefit from them, available drug types, expected results, and what patients can realistically hope for.
What Are Targeted Therapies in Lung Cancer?
Targeted therapies are medicines designed to attack specific genetic or molecular changes present in cancer cells.
Instead of killing all fast-growing cells (like chemotherapy), these drugs focus only on the cancer’s weak points.
Why this matters
- More effective in patients with specific mutations
- Fewer side effects
- Can be taken as oral tablets rather than IV drips
- Works even when chemotherapy stops working
How Targeted Therapies Work in Advanced Lung Cancer
Targeted therapy acts on molecular pathways that help cancer grow, multiply, or spread. By blocking these pathways, cancer cells lose the ability to survive.
Common ways targeted therapy works
- Blocks abnormal proteins that help cancer grow
- Stops the tumor from forming new blood vessels (anti-angiogenic therapy)
- Prevents cancer spread to other organs
- Triggers cancer cell death
These mechanisms give patients better disease control and a higher quality of life.
Who Is Eligible for Targeted Therapy?
Not everyone with advanced lung cancer automatically qualifies. A lot depends on genetic testing, also known as molecular testing or NGS (Next-Generation Sequencing).
Testing helps find mutations such as:
- EGFR
- ALK
- ROS1
- MET
- KRAS G12C
- RET
- BRAF V600E
- NTRK
If any of these are present, patients may benefit from targeted medicines tailored to that mutation.
Tests needed
- Tumor biopsy
- Liquid biopsy (blood-based test)
- Immunohistochemistry (IHC)
- PCR/NGS reports
Types of Targeted Therapies Used in Advanced Lung Cancer
Here’s a simple classification of targeted therapy drugs:
1. EGFR Inhibitors
Often used in non-small cell lung cancer with EGFR mutation.
Common drugs:
- Osimertinib
- Erlotinib
- Gefitinib
- Afatinib
Benefits:
- High response rate
- Oral medication
- Works well in lung cancer spread to the brain
2. ALK Inhibitors
For patients with ALK gene rearrangement.
Common drugs:
- Alectinib
- Crizotinib
- Lorlatinib
- Brigatinib
Benefits:
- Long survival
- Excellent brain penetration
- Fewer side effects
3. ROS1 Inhibitors
For ROS1-positive tumors.
Drugs used:
- Crizotinib
- Entrectinib
Benefits:
- Rapid symptom relief
- Good control of advanced disease
4. MET Inhibitors
For MET exon 14 skipping mutation.
Drugs:
- Capmatinib
- Tepotinib
5. KRAS G12C Inhibitors
A new advancement.
Drugs:
- Sotorasib
- Adagrasib
6. Anti-Angiogenic Therapies
These target tumor blood supply.
Drugs:
- Bevacizumab
- Ramucirumab
7. RET & NTRK Inhibitors
RET inhibitors: Selpercatinib, Pralsetinib
NTRK inhibitors: Larotrectinib, Entrectinib
How Effective Are Targeted Therapies in Advanced Lung Cancer?
Targeted therapy has significantly improved outcomes.
Benefits seen in many patients
- Tumor shrinkage in 60–80% of cases
- Longer progression-free survival
- Better tolerance compared to chemotherapy
- Can delay chemotherapy need
- Improves daily functioning and comfort
Expected Side Effects (Milder Than Chemotherapy)
Although easier to tolerate, targeted therapies still have some manageable side effects.
Common ones include:
- Mild skin rash
- Diarrhoea
- Tiredness
- Swelling of legs
- Mouth sores
- High blood pressure (with anti-angiogenics)
Rare but serious:
- Lung inflammation (pneumonitis)
- Liver enzyme elevation
- Heart rhythm changes
Doctors closely monitor and adjust doses when required.
Comparison: Targeted Therapy vs Chemotherapy
| Feature | Targeted Therapy | Chemotherapy |
|---|---|---|
| Precision | Acts on specific mutations | Attacks all fast-growing cells |
| Side effects | Mild to moderate | More intense |
| Mode | Mostly oral tablets | IV infusion |
| Suitability | Only if mutations present | Works for all lung cancers |
| Effectiveness | High when matched to mutation | Moderate |
How Long Does Targeted Therapy Continue?
Generally, targeted therapy continues as long as it works and side effects are manageable.
Typically:
- Patients stay on tablets for months to years
- Regular scans every 2–3 months
- Dose modifications if side effects occur
Once cancer stops responding, doctors explore other options like
- immunotherapy
- chemotherapy
- another targeted drug (if new mutation appears)
Why Targeted Therapy Is a Major Step Forward in Stage 3 & Stage 4 Lung Cancer
Patients with advanced lung cancer often feel they have limited options. Targeted therapy has changed this.
Key advantages
- Offers a personalized approach
- Improves survival
- Helps maintain normal lifestyle
- Works well even after spread to the brain
- Allows outpatient treatment
Lifestyle Tips to Improve Outcomes
While medicines work on the disease, simple lifestyle choices improve overall wellbeing.
Recommended changes:
- Balanced diet
- Adequate hydration
- Light exercises
- Stress management
- Avoid smoking & alcohol
- Regular follow-up scans
Short FAQ Section
- Does everyone with advanced lung cancer get targeted therapy?
No, Only those with specific gene mutations benefit from these treatments. - How is mutation testing done?
Via tumor biopsy or liquid biopsy (blood test). - Can targeted therapy cure advanced lung cancer?
It usually controls the disease for long periods but may not cure it completely. - Are side effects easier than chemotherapy?
Yes, Targeted therapy is typically better tolerated. - Can targeted therapy be combined with immunotherapy?
Not usually, Combinations can cause severe side effects, so doctors choose carefully.
Conclusion
Targeted therapies have transformed the way advanced lung cancer is treated. Instead of a one-size-fits-all approach, doctors now select treatments based on each patient’s unique cancer profile. These therapies provide better control, fewer side effects, and a more comfortable life even in advanced stages.
If you or your loved one has been diagnosed, asking your oncologist in ahmedabad about molecular testing is one of the most important steps in choosing the right treatment.